Atai Life Sciences Free Cash Flow 2020-2024 | ATAI
Atai Life Sciences free cash flow from 2020 to 2024. Free cash flow can be defined as a measure of financial performance calculated as operating cash flow minus capital expenditures.
| Atai Life Sciences Annual Free Cash Flow | |
|---|---|
| 2024 | -82.44 |
| 2023 | -84.38 |
| 2022 | -105.24 |
| 2021 | -63.42 |
| 2020 | -20.83 |
| 2019 | -7.87 |
| Atai Life Sciences Quarterly Free Cash Flow | |
|---|---|
| 2024-12-31 | -82.44 |
| 2024-09-30 | -58.14 |
| 2024-06-30 | -38.80 |
| 2024-03-31 | -22.57 |
| 2023-12-31 | -84.38 |
| 2023-09-30 | -62.41 |
| 2023-06-30 | -43.98 |
| 2023-03-31 | -21.39 |
| 2022-12-31 | -105.24 |
| 2022-09-30 | -74.59 |
| 2022-06-30 | -46.09 |
| 2022-03-31 | -24.04 |
| 2021-12-31 | -63.42 |
| 2021-09-30 | -42.86 |
| 2021-06-30 | -14.93 |
| 2021-03-31 | -16.70 |
| 2020-12-31 | -20.83 |
| 2020-09-30 | -14.56 |
| 2020-06-30 | -9.12 |
| 2020-03-31 | -3.89 |
| 2019-12-31 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical - Outpatient & Home Care | $0.305B | $0.000B |
| atai Life Sciences B.V. is a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders. atai Life Sciences B.V. is based in BERLIN. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Fresenius SE (FSNUY) | Germany | $21.804B | 0.00 |
| Quest Diagnostics (DGX) | United States | $19.317B | 19.51 |
| DaVita (DVA) | United States | $11.363B | 14.49 |
| Encompass Health (EHC) | United States | $9.962B | 22.32 |
| Chemed (CHE) | United States | $8.236B | 25.31 |
| Elanco Animal Health (ELAN) | United States | $5.492B | 13.07 |
| Option Care Health (OPCH) | United States | $5.459B | 25.87 |
| RadNet (RDNT) | United States | $4.453B | 98.62 |
| Amedisys (AMED) | United States | $2.998B | 21.34 |
| LifeStance Health (LFST) | United States | $2.904B | 0.00 |
| Addus HomeCare (ADUS) | United States | $1.974B | 22.91 |
| Astrana Health (ASTH) | United States | $1.946B | 26.61 |
| U.S Physical Therapy (USPH) | United States | $1.298B | 34.13 |
| Pennant (PNTG) | United States | $0.864B | 34.93 |
| Aveanna Healthcare Holdings (AVAH) | United States | $0.799B | 0.00 |
| Bioqual (BIOQ) | United States | $0.054B | 0.00 |
| Daxor (DXR) | United States | $0.036B | 0.00 |
| Ontrak (OTRK) | United States | $0.007B | 0.00 |
| MEDIROM Healthcare Technologies (MRM) | Japan | $0.004B | 0.00 |
| IMAC Holdings (BACK) | United States | $0.001B | 0.00 |
| Psychemedics (PMD) | United States | $0.000B | 0.00 |